Trial intelligence / Profile preview

FMT via Enema or Oral Route for RCDAD

NCT02449174Phase 2Completed

Sponsor
UTHealth Houston
Start
Mar 2015
Primary completion
Dec 2017
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 2 trial of Fecal Microbiota Transplantation Capsule in Clostridioides difficile infection (CDI), sponsored by UTHealth Houston. Started Mar 2015; status: completed.

02

Drugs

Fecal Microbiota Transplantation Capsule
03

Conditions

Clostridioides difficile infection (CDI)

Beyond the preview

Go deeper on NCT02449174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02449174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call